Digestive and Liver Disease · 2018 · 57 citations · 34 references
MedicineInternal MedicinePharmacotherapyClinical PharmacologyGastroenterologyGastrointestinal PharmacotherapyBowel Function AssessmentCrohn Disease PharmacotherapyInflammatory Bowel DiseaseBiochemical RemissionClinical Outcome MeasurementClinical RemissionComparative Drug SafetyDurable Clinical ResponseInflammatory Bowel Disease TherapyProduct Safety ProfileVedolizumab Therapy
34
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.2K citations
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text
Mark S. Silverberg, Jack Satsangi, Tariq Ahmad et al. · Canadian Journal of Gastroenterology · 2005 · 3.4K citations · Full text
A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY
Richard F. Harvey, J.M. Bradshaw · The Lancet · 1980 · 3K citations
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine · 2013 · 2.9K citations · Full text